Senate health committee chair plots future FDA changesnews2026-02-18T20:36:22+00:00February 18th, 2026|Endpoints News|
Reversal on Moderna’s flu application follows atypical path through FDAnews2026-02-18T15:45:05+00:00February 18th, 2026|Endpoints News|
FDA reverses course, will review Moderna’s flu vaccinenews2026-02-18T12:45:45+00:00February 18th, 2026|Endpoints News|
FDA rejects Disc Medicine’s rare disease drug despite granting it a commissioner vouchernews2026-02-17T16:14:16+00:00February 17th, 2026|Endpoints News|
Lilly appeals retatrutide classification ruling in case that could impact compoundersnews2026-02-13T17:31:04+00:00February 13th, 2026|Endpoints News|
Medtronic receives FDA clearance for Stealth AXiS™ surgical system | 1st Integrated planning, navigation and robotics platform for spine surgerynews2026-02-13T15:50:23+00:00February 13th, 2026|Medical Device News Magazine|
Pharma pushes back on FDA plans to ease prescription-OTC drug switchesnews2026-02-12T18:35:50+00:00February 12th, 2026|Endpoints News|
Controversy around FDA’s Prasad rises again after Moderna rejection, behavior allegationsnews2026-02-12T16:24:16+00:00February 12th, 2026|Endpoints News|
FDA may consider Moderna’s flu vaccine in a narrower groupnews2026-02-11T21:06:04+00:00February 11th, 2026|Endpoints News|
Prasad overruled vaccine review team, office director on Moderna flu shotnews2026-02-11T16:21:58+00:00February 11th, 2026|Endpoints News|
